Hangjun Zhan
Director/Board Member bei Vetmab Biosciences, Inc.
Profil
Hangjun Zhan is currently a Director at Vetmab Biosciences, Inc. He was previously the Chief Scientific Officer at Kindred Biosciences, Inc. from 2018 to 2021 and a Member at Aragen Bioscience, Inc. from 2010 to 2014.
Dr. Zhan has a graduate and doctorate degree from the University of Washington and an undergraduate degree from Zhejiang University, which he received in 1991.
Aktive Positionen von Hangjun Zhan
| Unternehmen | Position | Beginn |
|---|---|---|
Vetmab Biosciences, Inc.
 Vetmab Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Vetmab Biosciences, Inc. is an American company that is developing life-changing therapeutics for pets. The company specializes in monoclonal antibodies (mabs) for modern veterinary practices. The CEO of the company is Denise Marie Bevers. | Director/Board Member | - |
Ehemalige bekannte Positionen von Hangjun Zhan
| Unternehmen | Position | Ende |
|---|---|---|
| KINDRED BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01.06.2021 |
Aragen Bioscience, Inc.
 Aragen Bioscience, Inc. BiotechnologyHealth Technology Aragen Bioscience, Inc. operates as a contract research organization focused on accelerating product development through science, professionalism and innovation. Its services include antibody discovery, protein science, efficacy testing, and cell line development. The company was founded by Rick Srigley in 1993 and is headquartered in Morgan Hill, CA. | Corporate Officer/Principal | 01.02.2014 |
Ausbildung von Hangjun Zhan
| University of Washington | Doctorate Degree |
| Zhejiang University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. | Health Technology |
Vetmab Biosciences, Inc.
Vetmab Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Vetmab Biosciences, Inc. is an American company that is developing life-changing therapeutics for pets. The company specializes in monoclonal antibodies (mabs) for modern veterinary practices. The CEO of the company is Denise Marie Bevers. | Commercial Services |
Aragen Bioscience, Inc.
Aragen Bioscience, Inc. BiotechnologyHealth Technology Aragen Bioscience, Inc. operates as a contract research organization focused on accelerating product development through science, professionalism and innovation. Its services include antibody discovery, protein science, efficacy testing, and cell line development. The company was founded by Rick Srigley in 1993 and is headquartered in Morgan Hill, CA. | Health Technology |
